Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ...
The newly established high-tech laboratory at Biovac positions South Africa a step closer to achieving end-to-end vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback